Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015

INTRODUCTION: A small number of adverse events of seizure in patients using desloratadine (DL) have been reported. The European Medicines Agency requested a post-authorization safety study to investigate whether there is an association between DL exposure and seizure. OBJECTIVE: The aim was to study...

Descripción completa

Detalles Bibliográficos
Autores principales: Ersbøll, Annette Kjær, Sengupta, Kaushik, Pukkala, Eero, Bolin, Kristian, Aas, Eline, Emneus, Martha, Ramey, Dena Rosen, Brady, Joanne E., Mines, Daniel, Aasbjerg, Kristian, Vestergaard, Christian, Gislason, Gunnar, Born, Alfred Peter, Kjærulff, Thora Majlund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553702/
https://www.ncbi.nlm.nih.gov/pubmed/34609719
http://dx.doi.org/10.1007/s40264-021-01106-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553702/
https://www.ncbi.nlm.nih.gov/pubmed/34609719
http://dx.doi.org/10.1007/s40264-021-01106-7

Ejemplares similares